Physician profile
Eric Bendixen
NPI 1811458235
$1,926.09
in general payments reported to CMS, 2019-2025
10 companies · $407 in 2025
The $407 reported for 2025 was more than what 75% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $797 · 2021: $20.59 · 2022: $17.47 · 2023: $245 · 2024: $439 · 2025: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,091.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,090.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gemini Mountain Medical, LLC | $707.00 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $282.53 | 2025 | Dupixent |
| Grifols USA, LLC | $274.61 | 2023-2024 | Prolastin-C Liquid |
| Astrazeneca Pharmaceuticals Lp | $261.86 | 2023-2025 | Tezspire, Fasenra |
| United Therapeutics Corporation | $124.41 | 2024 | Tyvaso |
| Genzyme Corporation | $106.64 | 2024 | |
| Jazz Pharmaceuticals INC. | $90.31 | 2019 | |
| Philips North America LLC | $40.67 | 2024 | (Ak6) Vest Therapy |
| Amgen INC. | $20.59 | 2021 | |
| Pfizer INC. | $17.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Bendixen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.